Isala

Futó vizsgálatok

• Még nem toboroz

  Endoscopic (EID) Versus Surgical (TAMIS) Local Excision for Early Stage Rectal Cancer

  NCT07846046· Forrás

• Toboroz

  Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

  NCT07556887· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· 3. fázis· Forrás

• Toboroz

  Ultrasound of the Diaphragm Excursion Ratio as Physiological Biomarker in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  NCT07259174· Forrás

• Toboroz

  OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes

  NCT06476119· Forrás

• Toboroz

  Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC

  NCT06111807· Forrás

• Toboroz

  Observational Dutch Young Symptomatic StrokE studY - nEXT

  NCT05853796· Forrás

• Toboroz

  National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)

  NCT05326620· Forrás

• Fut, nem toboroz

  Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

  NCT05270044· 3. fázis· Forrás

• Fut, nem toboroz

  A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

  NCT04825743· 3. fázis· Forrás

• Toboroz

  Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision

  NCT05772923· Forrás

• Toboroz

  Prospective Bladder Cancer Infrastructure (ProBCI)

  NCT04503577· Forrás

• Fut, nem toboroz

  Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

  NCT03425838· 3. fázis· Forrás

• Toboroz

  Prospective Data Collection Initiative on Colorectal Cancer

  NCT02070146· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák3 toboroz
• Stroke (szélütés)2 toboroz
• Tüdőrák2 toboroz
• Hólyagrák1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes

  NCT04889183· 3. fázis· Forrás

• Lezárult

  Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

  NCT04437303· 4. fázis· Forrás

• Lezárult

  Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis

  NCT03593590· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· Forrás

• Lezárult

  Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation

  NCT02726698· Forrás